The Government of Canada announces biomanufacturing and life sciences strategy
The Government of Canada has already invested over $1.2billion to rebuild Canada's vaccine, therapeutics and biomanufacturing capacity right here at home.
- The Government of Canada has already invested over $1.2billion to rebuild Canada's vaccine, therapeutics and biomanufacturing capacity right here at home.
- As Canadians begin to look towards a post-pandemic future, the Government of Canada continues to build resiliency in Canada's biomanufacturing and life sciences sector as part of the government's recovery plan.
- Today, the Honourable Franois-Philippe Champagne, Minister of Innovation, Science and Industry, and the Honourable Patty Hajdu, Minister of Health, launched the Biomanufacturing and Life Sciences Strategy.
- The Biomanufacturing and Life Sciences Strategy is driven by two objectives: to grow a strong, competitive domestic life sciences sector, with cutting-edge biomanufacturing capabilities, while creating good jobs for Canadians, and to make sure Canada is prepared for pandemics and other health emergencies in the future.